Indicated for: antithrombin deficiency
Substance: human antithrombin III (coagulation factor)
ATC: B01AB02 (Blood and blood forming organs | Antithrombotic agents | Heparin group)
Antithrombin III human is a concentrated form of antithrombin derived from human plasma, used in the treatment and prevention of thrombotic complications in patients with congenital or acquired antithrombin deficiency. This natural protein inhibits enzymes in the coagulation cascade, including thrombin and factors Xa and IXa, preventing excessive blood clot formation.
Human antithrombin is administered intravenously, usually in emergency situations such as deep vein thrombosis, pulmonary embolism, or during surgical procedures in patients at high risk of thrombosis.
Side effects are rare but may include allergic reactions, fever, or thrombocytopenia. Administration must be performed under strict medical supervision, with careful monitoring of coagulation parameters.
Antithrombin III human is a vital medication for managing coagulation disorders, helping to prevent severe complications and maintain hemostatic balance.